nodes	percent_of_prediction	percent_of_DWPC	metapath
Salsalate—Labetalol—Formoterol—chronic obstructive pulmonary disease	0.348	0.5	CrCrCtD
Salsalate—Labetalol—Arformoterol—chronic obstructive pulmonary disease	0.348	0.5	CrCrCtD
Salsalate—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.205	1	CbGbCtD
Salsalate—PTGS1—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.00215	0.0948	CbGpPWpGaD
Salsalate—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00177	0.0273	CcSEcCtD
Salsalate—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00174	0.0269	CcSEcCtD
Salsalate—PTGS2—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.00171	0.0753	CbGpPWpGaD
Salsalate—Acetylsalicylic acid—TP53—chronic obstructive pulmonary disease	0.00155	0.228	CrCbGaD
Salsalate—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.00139	0.0214	CcSEcCtD
Salsalate—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.00139	0.0214	CcSEcCtD
Salsalate—PTGS2—leg—chronic obstructive pulmonary disease	0.00135	0.311	CbGeAlD
Salsalate—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.0202	CcSEcCtD
Salsalate—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00129	0.02	CcSEcCtD
Salsalate—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00126	0.0194	CcSEcCtD
Salsalate—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00125	0.0193	CcSEcCtD
Salsalate—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00111	0.0172	CcSEcCtD
Salsalate—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00111	0.0171	CcSEcCtD
Salsalate—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00108	0.0167	CcSEcCtD
Salsalate—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.0166	CcSEcCtD
Salsalate—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.0165	CcSEcCtD
Salsalate—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00106	0.0163	CcSEcCtD
Salsalate—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000998	0.0154	CcSEcCtD
Salsalate—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000997	0.0154	CcSEcCtD
Salsalate—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000995	0.0154	CcSEcCtD
Salsalate—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000986	0.0152	CcSEcCtD
Salsalate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00094	0.0145	CcSEcCtD
Salsalate—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000899	0.0139	CcSEcCtD
Salsalate—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000899	0.0139	CcSEcCtD
Salsalate—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000881	0.0136	CcSEcCtD
Salsalate—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000863	0.0133	CcSEcCtD
Salsalate—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000849	0.0131	CcSEcCtD
Salsalate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000838	0.0129	CcSEcCtD
Salsalate—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000835	0.0129	CcSEcCtD
Salsalate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000834	0.0129	CcSEcCtD
Salsalate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000814	0.0126	CcSEcCtD
Salsalate—PTGS1—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	0.000803	0.0354	CbGpPWpGaD
Salsalate—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000803	0.0124	CcSEcCtD
Salsalate—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000803	0.0124	CcSEcCtD
Salsalate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00079	0.0122	CcSEcCtD
Salsalate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000787	0.0121	CcSEcCtD
Salsalate—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000787	0.0121	CcSEcCtD
Salsalate—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000758	0.0117	CcSEcCtD
Salsalate—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00075	0.0116	CcSEcCtD
Salsalate—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00075	0.0116	CcSEcCtD
Salsalate—PTGS2—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	0.00075	0.033	CbGpPWpGaD
Salsalate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000722	0.0111	CcSEcCtD
Salsalate—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000709	0.0109	CcSEcCtD
Salsalate—Ketoprofen—CXCL8—chronic obstructive pulmonary disease	0.00068	0.0998	CrCbGaD
Salsalate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000665	0.0103	CcSEcCtD
Salsalate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000665	0.0103	CcSEcCtD
Salsalate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000657	0.0101	CcSEcCtD
Salsalate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000657	0.0101	CcSEcCtD
Salsalate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000643	0.00992	CcSEcCtD
Salsalate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000638	0.00984	CcSEcCtD
Salsalate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000638	0.00984	CcSEcCtD
Salsalate—PTGS2—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	0.000638	0.0281	CbGpPWpGaD
Salsalate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000635	0.00979	CcSEcCtD
Salsalate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000635	0.00979	CcSEcCtD
Salsalate—PTGS1—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.000629	0.0277	CbGpPWpGaD
Salsalate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000627	0.00968	CcSEcCtD
Salsalate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000627	0.00967	CcSEcCtD
Salsalate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000627	0.00967	CcSEcCtD
Salsalate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000625	0.00964	CcSEcCtD
Salsalate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000622	0.00959	CcSEcCtD
Salsalate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00062	0.00957	CcSEcCtD
Salsalate—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000615	0.00949	CcSEcCtD
Salsalate—Labetalol—ADRB2—chronic obstructive pulmonary disease	0.000613	0.09	CrCbGaD
Salsalate—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000612	0.00944	CcSEcCtD
Salsalate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000602	0.00929	CcSEcCtD
Salsalate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000599	0.00925	CcSEcCtD
Salsalate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000591	0.00912	CcSEcCtD
Salsalate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—chronic obstructive pulmonary disease	0.00058	0.0255	CbGpPWpGaD
Salsalate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000549	0.00848	CcSEcCtD
Salsalate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000549	0.00848	CcSEcCtD
Salsalate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000538	0.0083	CcSEcCtD
Salsalate—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.000525	0.0231	CbGpPWpGaD
Salsalate—PTGS1—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000523	0.023	CbGpPWpGaD
Salsalate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000519	0.008	CcSEcCtD
Salsalate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000506	0.00781	CcSEcCtD
Salsalate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000506	0.00781	CcSEcCtD
Salsalate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000506	0.0078	CcSEcCtD
Salsalate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000506	0.0078	CcSEcCtD
Salsalate—PTGS2—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.000499	0.022	CbGpPWpGaD
Salsalate—Rash—Montelukast—chronic obstructive pulmonary disease	0.000496	0.00765	CcSEcCtD
Salsalate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000495	0.00764	CcSEcCtD
Salsalate—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000487	0.00751	CcSEcCtD
Salsalate—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000479	0.00739	CcSEcCtD
Salsalate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000478	0.00738	CcSEcCtD
Salsalate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000478	0.00737	CcSEcCtD
Salsalate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000477	0.00736	CcSEcCtD
Salsalate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000477	0.00736	CcSEcCtD
Salsalate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000467	0.00721	CcSEcCtD
Salsalate—PTGS2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000454	0.02	CbGpPWpGaD
Salsalate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.00695	CcSEcCtD
Salsalate—PTGS1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00045	0.0198	CbGpPWpGaD
Salsalate—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000447	0.0069	CcSEcCtD
Salsalate—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000445	0.00686	CcSEcCtD
Salsalate—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000435	0.00671	CcSEcCtD
Salsalate—Magnesium salicylate—ALB—chronic obstructive pulmonary disease	0.000426	0.0626	CrCbGaD
Salsalate—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.000417	0.0184	CbGpPWpGaD
Salsalate—PTGS2—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000415	0.0183	CbGpPWpGaD
Salsalate—Warfarin—CYP1A1—chronic obstructive pulmonary disease	0.000412	0.0604	CrCbGaD
Salsalate—PTGS1—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.000409	0.018	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—MMP12—chronic obstructive pulmonary disease	0.000407	0.0179	CbGpPWpGaD
Salsalate—Diflunisal—ALB—chronic obstructive pulmonary disease	0.000401	0.0588	CrCbGaD
Salsalate—Warfarin—CYP1A2—chronic obstructive pulmonary disease	0.000397	0.0582	CrCbGaD
Salsalate—Propafenone—CYP1A2—chronic obstructive pulmonary disease	0.000388	0.0569	CrCbGaD
Salsalate—PTGS2—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.000382	0.0168	CbGpPWpGaD
Salsalate—PTGS2—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000357	0.0157	CbGpPWpGaD
Salsalate—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000354	0.00546	CcSEcCtD
Salsalate—PTGS1—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000351	0.0155	CbGpPWpGaD
Salsalate—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.00035	0.0808	CbGeAlD
Salsalate—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000348	0.00537	CcSEcCtD
Salsalate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000345	0.00533	CcSEcCtD
Salsalate—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.000335	0.0773	CbGeAlD
Salsalate—PTGS1—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000327	0.0144	CbGpPWpGaD
Salsalate—PTGS2—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.000325	0.0143	CbGpPWpGaD
Salsalate—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000316	0.00488	CcSEcCtD
Salsalate—PTGS1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000315	0.0139	CbGpPWpGaD
Salsalate—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.000308	0.0711	CbGeAlD
Salsalate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	0.000303	0.0133	CbGpPWpGaD
Salsalate—Fenoprofen—ALB—chronic obstructive pulmonary disease	0.0003	0.044	CrCbGaD
Salsalate—Carbamazepine—CYP1A2—chronic obstructive pulmonary disease	0.000297	0.0435	CrCbGaD
Salsalate—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.000295	0.068	CbGeAlD
Salsalate—PTGS2—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.000289	0.0127	CbGpPWpGaD
Salsalate—PTGS1—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000285	0.0125	CbGpPWpGaD
Salsalate—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000282	0.0651	CbGeAlD
Salsalate—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.000279	0.0123	CbGpPWpGaD
Salsalate—PTGS2—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000279	0.0123	CbGpPWpGaD
Salsalate—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000278	0.0122	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000277	0.0122	CbGpPWpGaD
Salsalate—PTGS2—bronchus—chronic obstructive pulmonary disease	0.000275	0.0636	CbGeAlD
Salsalate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000274	0.00423	CcSEcCtD
Salsalate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000274	0.00423	CcSEcCtD
Salsalate—Acetylsalicylic acid—ALB—chronic obstructive pulmonary disease	0.000271	0.0397	CrCbGaD
Salsalate—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000269	0.0622	CbGeAlD
Salsalate—PTGS2—S1P1 pathway—VEGFA—chronic obstructive pulmonary disease	0.000264	0.0116	CbGpPWpGaD
Salsalate—PTGS2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00026	0.0114	CbGpPWpGaD
Salsalate—PTGS1—trachea—chronic obstructive pulmonary disease	0.000259	0.0597	CbGeAlD
Salsalate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000258	0.00399	CcSEcCtD
Salsalate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000258	0.00399	CcSEcCtD
Salsalate—Oxcarbazepine—ALB—chronic obstructive pulmonary disease	0.000251	0.0369	CrCbGaD
Salsalate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000251	0.00387	CcSEcCtD
Salsalate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00025	0.00385	CcSEcCtD
Salsalate—PTGS2—trachea—chronic obstructive pulmonary disease	0.000247	0.0571	CbGeAlD
Salsalate—PTGS1—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.00023	0.0101	CbGpPWpGaD
Salsalate—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000229	0.0101	CbGpPWpGaD
Salsalate—Warfarin—ALB—chronic obstructive pulmonary disease	0.000229	0.0336	CrCbGaD
Salsalate—PTGS2—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000226	0.00996	CbGpPWpGaD
Salsalate—Salicylic acid—ALB—chronic obstructive pulmonary disease	0.000223	0.0327	CrCbGaD
Salsalate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000216	0.00334	CcSEcCtD
Salsalate—PTGS1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000202	0.00888	CbGpPWpGaD
Salsalate—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000199	0.00878	CbGpPWpGaD
Salsalate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000199	0.00307	CcSEcCtD
Salsalate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000199	0.00307	CcSEcCtD
Salsalate—Flurbiprofen—ALB—chronic obstructive pulmonary disease	0.000195	0.0287	CrCbGaD
Salsalate—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000188	0.0029	CcSEcCtD
Salsalate—PTGS1—lung—chronic obstructive pulmonary disease	0.000186	0.0429	CbGeAlD
Salsalate—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000185	0.00813	CbGpPWpGaD
Salsalate—PTGS2—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000182	0.00804	CbGpPWpGaD
Salsalate—PTGS2—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.000181	0.00797	CbGpPWpGaD
Salsalate—PTGS2—lung—chronic obstructive pulmonary disease	0.000178	0.041	CbGeAlD
Salsalate—Ketoprofen—ALB—chronic obstructive pulmonary disease	0.000177	0.0259	CrCbGaD
Salsalate—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000168	0.00738	CbGpPWpGaD
Salsalate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	0.00015	0.0066	CbGpPWpGaD
Salsalate—PTGS2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000147	0.00646	CbGpPWpGaD
Salsalate—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000142	0.00624	CbGpPWpGaD
Salsalate—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000142	0.00624	CbGpPWpGaD
Salsalate—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000141	0.00623	CbGpPWpGaD
Salsalate—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00014	0.00616	CbGpPWpGaD
Salsalate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.00013	0.00573	CbGpPWpGaD
Salsalate—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000128	0.00566	CbGpPWpGaD
Salsalate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.000122	0.00539	CbGpPWpGaD
Salsalate—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.00536	CbGpPWpGaD
Salsalate—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.000117	0.00516	CbGpPWpGaD
Salsalate—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000115	0.00507	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	0.000113	0.005	CbGpPWpGaD
Salsalate—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000113	0.00496	CbGpPWpGaD
Salsalate—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000113	0.00496	CbGpPWpGaD
Salsalate—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000112	0.00495	CbGpPWpGaD
Salsalate—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.000111	0.00491	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	0.000111	0.00489	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	0.000106	0.00466	CbGpPWpGaD
Salsalate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	0.000104	0.00459	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	9.8e-05	0.00432	CbGpPWpGaD
Salsalate—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	9.14e-05	0.00403	CbGpPWpGaD
Salsalate—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	8.36e-05	0.00368	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	7.78e-05	0.00343	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	7.54e-05	0.00332	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	7.23e-05	0.00318	CbGpPWpGaD
Salsalate—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.98e-05	0.00308	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	6.82e-05	0.003	CbGpPWpGaD
Salsalate—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	6.74e-05	0.00297	CbGpPWpGaD
Salsalate—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	6.63e-05	0.00292	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.49e-05	0.00286	CbGpPWpGaD
Salsalate—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.43e-05	0.00283	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	6.31e-05	0.00278	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.87e-05	0.00259	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	5.62e-05	0.00247	CbGpPWpGaD
Salsalate—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.54e-05	0.00244	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	5.51e-05	0.00243	CbGpPWpGaD
Salsalate—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	5.35e-05	0.00236	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	5.25e-05	0.00231	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.15e-05	0.00227	CbGpPWpGaD
Salsalate—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.11e-05	0.00225	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	5.01e-05	0.00221	CbGpPWpGaD
Salsalate—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.68e-05	0.00206	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.66e-05	0.00205	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	4.62e-05	0.00204	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	4.23e-05	0.00186	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.16e-05	0.00183	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.82e-05	0.00168	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.75e-05	0.00165	CbGpPWpGaD
Salsalate—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.71e-05	0.00164	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.57e-05	0.00157	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.45e-05	0.00152	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.41e-05	0.0015	CbGpPWpGaD
Salsalate—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.18e-05	0.0014	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.15e-05	0.00139	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.11e-05	0.00137	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.87e-05	0.00126	CbGpPWpGaD
Salsalate—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	2.75e-05	0.00121	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.74e-05	0.00121	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.71e-05	0.00119	CbGpPWpGaD
Salsalate—PTGS2—Disease—KL—chronic obstructive pulmonary disease	2.55e-05	0.00113	CbGpPWpGaD
Salsalate—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.52e-05	0.00111	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.47e-05	0.00109	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.39e-05	0.00105	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.36e-05	0.00104	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.27e-05	0.001	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.2e-05	0.000968	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.08e-05	0.000917	CbGpPWpGaD
Salsalate—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	1.91e-05	0.000843	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.9e-05	0.000836	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.87e-05	0.000824	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.74e-05	0.000768	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.65e-05	0.000728	CbGpPWpGaD
Salsalate—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	1.6e-05	0.000703	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	1.42e-05	0.000624	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.35e-05	0.000596	CbGpPWpGaD
Salsalate—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	1.34e-05	0.000592	CbGpPWpGaD
Salsalate—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	1.28e-05	0.000565	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	1.12e-05	0.000495	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.07e-05	0.000473	CbGpPWpGaD
Salsalate—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	8.49e-06	0.000374	CbGpPWpGaD
Salsalate—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	8.32e-06	0.000367	CbGpPWpGaD
Salsalate—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	6.39e-06	0.000282	CbGpPWpGaD
